Screener
Tyra Biosciences, Inc. TYRA Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 298,511 | 178,616 |
| Prepaid expenses and other current assets | 11,147 | 9,447 |
| Total current assets | 394,613 | 265,450 |
| Restricted cash | 884 | 1,000 |
| Property and equipment, net | 1,215 | 1,314 |
| Right-of-use assets | 5,443 | 5,573 |
| Other long-term assets | 9,885 | 9,272 |
| Total assets | $412,040 | $282,609 |
Item 1. Condensed Financial Statements
FAQ
- What is Tyra Biosciences, Inc.'s restricted cash?
- Tyra Biosciences, Inc. (TYRA) reported restricted cash of $884K in Q1 2026.
- How has Tyra Biosciences, Inc.'s restricted cash changed year-over-year?
- Tyra Biosciences, Inc.'s restricted cash decreased by 11.6% year-over-year, from $1M to $884K.
- What is the long-term trend for Tyra Biosciences, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s restricted cash has grown at a 32.7% compound annual growth rate (CAGR), from $243K to $1M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Tyra Biosciences, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude